Drug Trials Snapshots: BEYFORTUS

• 2024

  Sign in to bookmark this resource.

  Sign in

---

Access Resources

• SummaryEN

About

This webpage features a drug trial snapshot for the drug Beyfortus, a monoclonal antibody given as an injection to protect against RSV. Snapshots reveal participants in clinical trials for FDA drug approval, analyzing variations in sex, race, age, and ethnicity. "MORE INFO" offers in-depth details. Consumers can use Snapshots to weigh drug risks and benefits.

---

Tags

Focus Area: Infectious Disease

Audiences: Families & Children; Nurses; Physicians; Public Health Professionals

Emergency Management Stage: Preparedness (Prevention / Protection)

Collection: Nirsevimab Library

Keywords: Demography; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Clinical Trial; Antibodies, Monoclonal, Humanized

Institutions: U.S. Food and Drug Administration

---

More like this

FDA Approves a New Antibody Drug to Prevent RSV in Babies 2023 · National Public Radio (NPR) Candida auris (C. auris) None · Centers for Disease Control and Prevention (CDC) Emergency Use Authorization 2024 · U.S. Food and Drug Administration

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---